- Home
- FGI vs MBIO Comparison
FGI vs MBIO Comparison
Compare FGI & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- MBIO
- Stock Information
- Founded
- FGI 1987
- MBIO 2015
- Country
- FGI United States
- MBIO United States
- Employees
- FGI N/A
- MBIO N/A
- Industry
- FGI Industrial Specialties
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- MBIO Health Care
- Exchange
- FGI Nasdaq
- MBIO Nasdaq
- Market Cap
- FGI 8.0M
- MBIO 7.3M
- IPO Year
- FGI 2022
- MBIO N/A
- Fundamental
- Price
- FGI $0.84
- MBIO $4.17
- Analyst Decision
- FGI
- MBIO Strong Buy
- Analyst Count
- FGI 0
- MBIO 1
- Target Price
- FGI N/A
- MBIO $2.00
- AVG Volume (30 Days)
- FGI 11.0K
- MBIO 478.1K
- Earning Date
- FGI 11-11-2024
- MBIO 03-10-2025
- Dividend Yield
- FGI N/A
- MBIO N/A
- EPS Growth
- FGI N/A
- MBIO N/A
- EPS
- FGI N/A
- MBIO N/A
- Revenue
- FGI $127,180,460.00
- MBIO N/A
- Revenue This Year
- FGI $11.39
- MBIO N/A
- Revenue Next Year
- FGI $6.26
- MBIO N/A
- P/E Ratio
- FGI N/A
- MBIO N/A
- Revenue Growth
- FGI 7.71
- MBIO N/A
- 52 Week Low
- FGI $0.70
- MBIO $3.72
- 52 Week High
- FGI $1.85
- MBIO $76.00
- Technical
- Relative Strength Index (RSI)
- FGI 52.47
- MBIO 27.51
- Support Level
- FGI $0.76
- MBIO $9.65
- Resistance Level
- FGI $0.89
- MBIO $13.30
- Average True Range (ATR)
- FGI 0.04
- MBIO 2.34
- MACD
- FGI 0.00
- MBIO -0.65
- Stochastic Oscillator
- FGI 43.82
- MBIO 2.47
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.